Armata Pharmaceuticals, Inc. (ARMP): Capital Expenditures
$542.0K
Year ended 2025-12-31
$374.0K
Trailing 12 months to 2026-06-30
-37.4%
3-year compound annual growth
-8.0%
5-year compound annual growth
+9.9%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $542.0K | -71.2% | 2026-03-25, From 2025-01-01 |
| 2024-12-31 | $1.88M | -76.9% | 2026-03-25, From 2024-01-01 |
| 2023-12-31 | $8.14M | +268.3% | 2025-03-21, From 2023-01-01 |
| 2022-12-31 | $2.21M | +69.6% | 2024-03-21, From 2022-01-01 |
| 2021-12-31 | $1.30M | +58.3% | 2023-03-16, From 2021-01-01 |
| 2020-12-31 | $824.0K | +267.9% | 2022-03-17, From 2020-01-01 |
| 2019-12-31 | $224.0K | -74.4% | 2021-03-18, From 2019-01-01 |
| 2018-12-31 | $875.0K | n/m | 2020-03-19, From 2018-01-01 |
| 2017-12-31 | $58.0K | -79.2% | 2019-03-25, From 2017-01-01 |
| 2016-12-31 | $279.0K | +32.9% | 2018-03-14, From 2016-01-01 |
| 2015-12-31 | $210.0K | -82.5% | 2017-03-27, From 2015-01-01 |
| 2014-12-31 | $1.20M | n/m | 2016-03-30, From 2014-01-01 |
| 2013-12-31 | $102.0K | n/a | 2015-04-15, From 2013-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Armata Pharmaceuticals, Inc. (ARMP) | 2025-12-31 | $542.0K | -71.2% |
| Alpha Cognition Inc. (ACOG) | 2025-12-31 | $293.5K | +999.2% |
| Protalix BioTherapeutics, Inc. (PLX) | 2025-12-31 | $1.64M | +27.8% |
| Aligos Therapeutics, Inc. (ALGS) | 2024-12-31 | $130.0K | +584.2% |
| LeonaBio, Inc. (LONA) | 2024-12-31 | $33.0K | -89.1% |
| aTYR PHARMA INC (ATYR) | 2025-12-31 | $77.0K | +18.5% |
| Quince Therapeutics, Inc. (QNCX) | 2025-12-31 | $352.0K | +37.0% |
| Elutia Inc. (ELUT) | 2025-12-31 | $1.88M | +186.9% |
| Passage BIO, Inc. (PASG) | 2024-12-31 | $34.0K | n/a |
Compare ARMP, ACOG, PLX, ALGS side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗